Sexually Transmitted Disease (STD) Diagnostics Market Report by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others)

Sexually Transmitted Disease (STD) Diagnostics Market Report by Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others), Device Type (Laboratory Devices, Point of Care (PoC) Devices), End User (Laboratory Testing, Point of Care (PoC) Testing), and Region 2024-2032

The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. The rising prevalence of STDs, increasing awareness among the masses regarding early diagnosis, and the introduction of at-home STD testing kits represent some of the key factors driving the market.

Sexually transmitted disease (STD) diagnostics refer to examinations, tests, and swab cultures performed to identify and confirm the presence of STDs. It includes blood, fluid sample, and urine tests to detect the presence of antibodies or antigens of certain STDs. It is widely used to detect and screen various sexually transmitted diseases and infections, such as genital herpes, chlamydia, gonorrhea, syphilis, pubic lice, trichomoniasis, acquired immune deficiency syndrome (AIDS), bacterial vaginosis, scabies, and chancroid. STD diagnostics aids in early detection and accurate treatment, prevents infertility, protects unborn children from infection, and minimizes the spread of diseases. These diagnostic methods also help in reducing the chance of long-term risks, boosting confidence, and providing physicians with valuable insight into diseases and their causes.

Sexually Transmitted Disease (STD) Diagnostics Market Trends:
The rising prevalence of sexually transmitted diseases (STDs) due to unprotected sexual intercourse and drug abuse is one of the key factors driving the market growth. STD diagnostics are widely used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in determining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. In addition to this, the increasing awareness among the masses regarding early detection and diagnosis of STDs, which can prevent long-term complications, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to the market growth. Additionally, the introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the market growth. Moreover, the recent development of artificial intelligence (AI) – based mobile applications that can diagnose STDs by analyzing digital images of an individual’s private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development (R&D) of novel diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global sexually transmitted disease (STD) diagnostics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, device type, and end user.

Type Insights:

Chlamydia Testing
Syphilis Testing
Gonorrhea Testing
Herpes Simplex Virus Testing
Human Papilloma Virus Testing
Human Immunodeficiency Virus Testing
Chancroid Testing
Others

The report has provided a detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the type. This includes chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, chancroid testing, and others. According to the report, chlamydia testing represented the largest segment.

Device Type Insights:

Laboratory Devices
Thermal Cycler – PCR
Lateral Flow Readers
Flow Cytometers
Absorbance Microplate Reader – Enzyme Linked Immunosorbent Assay (ELISA)
Others
Point of Care (PoC) Devices
Phone Chips (Microfluidics + ICT)
Portable/Bench Top/Rapid Diagnostic Kits

A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the device type has also been provided in the report. This includes laboratory devices (thermal cycler – PCR, lateral flow readers, flow cytometers, absorbance microplate reader – enzyme linked immunosorbent assay (ELISA), and others) and point of care (PoC) devices (phone chips (microfluidic + ICT) and portable/bench top/rapid diagnostic kits). According to the report, laboratory devices accounted for the largest market share.

End User Insights:

Laboratory Testing
Point of Care (PoC) Testing

A detailed breakup and analysis of the sexually transmitted disease (STD) diagnostics market based on the end user has also been provided in the report. This includes laboratory and point of care (PoC) testing. According to the report, laboratory testing accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for sexually transmitted disease (STD) diagnostics. Some of the factors driving the North America sexually transmitted disease (STD) diagnostics market included the rising prevalence of STDs, extensive research and development (R&D) activities, and significant growth in the healthcare industry.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global sexually transmitted disease (STD) diagnostics market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Becton Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories Inc., Cepheid (Danaher Corporation), F. Hoffmann-La Roche AG, Hologic Inc., Qiagen N.V., Quidel Corporation, Siemens Healthineers AG (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global sexually transmitted disease (STD) diagnostics market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global sexually transmitted disease (STD) diagnostics market?
What is the impact of each driver, restraint, and opportunity on the global sexually transmitted disease (STD) diagnostics market?
What are the key regional markets?
Which countries represent the most attractive sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on the type?
Which is the most attractive type in the sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on the device type?
Which is the most attractive device type in the sexually transmitted disease (STD) diagnostics market?
What is the breakup of the market based on end user?
Which is the most attractive end user in the sexually transmitted disease (STD) diagnostics market?
What is the competitive structure of the global sexually transmitted disease (STD) diagnostics market?
Who are the key players/companies in the global sexually transmitted disease (STD) diagnostics market?